Eton Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Eton Pharmaceuticals, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q2 2024.
  • Eton Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 25.8K shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 25.8K* -205 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 25.8K* +238 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 25.7M +354K +1.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 26K* -25.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 25.5K* -25.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 25.4M +89K +0.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 25.1M +25.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 25.3M -1.25M -4.69% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q3 2021 25.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 25.2K* -21M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 26.5M +8.4M +46.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2020 21M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 18.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.